Curious cases of financial engineering in biotech
owlposting.com · 7,048 words · saved by 2 readers
7k words, 32 minutes reading time
Primers Curious cases of financial engineering in biotech 7k words, 32 minutes reading time Abhishaike Mahajan Apr 27, 2026 214 9 33 Share Note: finance topics are slightly sensitive, so, while nothing in this article contains proprietary information, I will not include the names of people I talked with for this piece. I appreciate everyone who reached out to help me put this together! Edit: The follow-up to this article has been published: How financial architectures shaped (and will continue to shape) Chinese drug development . Introduction Finance tries to make failure survivable: the Andre
saved by
related reading
- Companies that should exist - Anastasia Gamickanastasiagamick.substack.com
- Early-Stage Biotech Value Creation: The Roles of Equity and Partnershipsleadershipandbiotechnology.blogspot.com
- Where are all the trillion dollar biotechs?ladanuzhna.xyz
- Tech vs Biotech - Celine Haliouacelinehh.com
- Biotech’s Dulcius Ex Asperis: The Way Through This Downturn - RApportrapport.bio
- The Biotech Delusion: Things No One Wants to Admitmattshlosberg.substack.com
- Hub-and-Spoke Biotechs: BridgeBio - by Elliot Hershbergcenturyofbio.com
- On Medici and Thiel - by Rohit Krishnanstrangeloopcanon.com
- AI Versus Eroom's Lawsubstack.com
- Anatomy of a Biotech Business Development Deal | Andreessen Horowitza16z.com
- Biotech Startups: Move Slow and Fix Things - Stanford Biotechnology Groupstanfordbiotechgroup.com
- Fundraising for Founder-led Biotech – Matt Krisiloffmattkrisiloff.com